Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer, Stage IV Melanoma, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor and Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial Using propranolol hydrochloride and Correlative Studies

- The folks at Ohio State University Comprehensive Cancer Center are studying the effects of propranolol hydrochloride; Correlative Studies on Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer, Stage IV Melanoma, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor and Unspecified Adult Solid Tumor, Protocol Specific in individuals ages 18 years and older. This clinical trial is slated to start January 2014.

1-800-293-5066
The Ohio State University Comprehensive Cancer Center
Overall Study Contact Info
StatusName Contact Phone
RecruitingThe Ohio State University Comprehensive Cancer CenterJamesline@osumc.edu1-800-293-5066

This study is officially titled, "A Pilot Study of Beta-Blockers in Patients With Advanced Cancer."

Locations

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Columbus, Ohio - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.